Clinical Trials Browser

Has results × Melanoma × lorukafusp alfa × Clear all

NCT03958383 2026-06-03

IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma

Phase 1/2 Terminated

8 enrolled 12 charts

Melanoma

NCT00590824 2019-11-21

Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma

Phase 2 Completed

23 enrolled 22 charts

Melanoma